115 related articles for article (PubMed ID: 8647655)
41. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide].
Wang CH; Tang CW
Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891
[TBL] [Abstract][Full Text] [Related]
42. [Antitumor effects of a new antitumor agent, zinostatin stimalamer (YM881)--effects on experimental tumors in vitro and in vivo].
Numasaki Y; Takahashi K; Masuda E; Nohara C; Maeda H
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2289-94. PubMed ID: 1834021
[TBL] [Abstract][Full Text] [Related]
43. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
44. In vivo studies of the new gonadotropin-releasing hormone antagonist--copolymer conjugates having antitumor activity.
Vincze B; Pályi I; Gaál D; Pató J; Móra M; Mezõ I; Teplán I; Seprõdi J
Cancer Detect Prev; 1996; 20(2):153-9. PubMed ID: 8706041
[TBL] [Abstract][Full Text] [Related]
45. Changes in sensitivity to cyclophosphamide of mouse mammary tumors during serial transplantation.
Sluyser M; De Goeij CC; Evers SG
J Natl Cancer Inst; 1981 Feb; 66(2):327-30. PubMed ID: 6935481
[TBL] [Abstract][Full Text] [Related]
46. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
47. Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts.
Dolan ME; Fleig MJ; Feuerstein BG; Basu HS; Luk GD; Casero RA; Marton LJ
Cancer Res; 1994 Sep; 54(17):4698-702. PubMed ID: 8062267
[TBL] [Abstract][Full Text] [Related]
48. Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
Bischoff ED; Gottardis MM; Moon TE; Heyman RA; Lamph WW
Cancer Res; 1998 Feb; 58(3):479-84. PubMed ID: 9458093
[TBL] [Abstract][Full Text] [Related]
49. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance.
Cassoni P; Fulcheri E; Carcangiu ML; Stella A; Deaglio S; Bussolati G
J Pathol; 2000 Mar; 190(4):470-7. PubMed ID: 10699997
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095).
Radulovic S; Miller G; Schally AV
Cancer Res; 1991 Nov; 51(21):6006-9. PubMed ID: 1682040
[TBL] [Abstract][Full Text] [Related]
51. cis-hydroxyproline stimulates the growth of rat mammary carcinoma cells.
Buck TB; Hall AL; Sinha CC; Bunce OR; Thorgeirsson UP
In Vivo; 2000; 14(1):7-11. PubMed ID: 10757055
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice.
Ovejera AA; Houchens DP; Catane R; Sheridan MA; Muggia FM
Cancer Res; 1979 Aug; 39(8):3220-4. PubMed ID: 572261
[TBL] [Abstract][Full Text] [Related]
53. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion.
Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW
Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054
[TBL] [Abstract][Full Text] [Related]
54. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of PKCalpha is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model.
Lin X; Yu Y; Zhao H; Zhang Y; Manela J; Tonetti DA
Carcinogenesis; 2006 Aug; 27(8):1538-46. PubMed ID: 16513679
[TBL] [Abstract][Full Text] [Related]
56. Liposomal prednisolone inhibits tumor growth in a spontaneous mouse mammary carcinoma model.
Deshantri AK; Kooijmans SA; Kuijpers SA; Coimbra M; Hoeppener A; Storm G; Fens MH; Schiffelers RM
J Control Release; 2016 Dec; 243():243-249. PubMed ID: 27773734
[TBL] [Abstract][Full Text] [Related]
57. Inhibiting effect of ascorbic acid on the growth of human mammary tumor xenografts.
Tsao CS
Am J Clin Nutr; 1991 Dec; 54(6 Suppl):1274S-1280S. PubMed ID: 1962582
[TBL] [Abstract][Full Text] [Related]
58. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A.
Cassoni P; Sapino A; Fortunati N; Munaron L; Chini B; Bussolati G
Int J Cancer; 1997 Jul; 72(2):340-4. PubMed ID: 9219843
[TBL] [Abstract][Full Text] [Related]
59. Imaging tumor cell movement in vivo.
Kedrin D; Wyckoff J; Sahai E; Condeelis J; Segall JE
Curr Protoc Cell Biol; 2007 Jun; Chapter 19():Unit 19.7. PubMed ID: 18228501
[TBL] [Abstract][Full Text] [Related]
60. The adjuvant effect of oxytocin on GnRH analogue buserelin.
Heberal A; Batioglu S; Celikkanat H
J Pak Med Assoc; 1996 Jun; 46(6):134-5. PubMed ID: 8991372
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
